Redesigning the Rules of Drug Discovery Through Protein Degradation
The rise of targeted protein degradation (TPD) has opened a new chapter in modern drug discovery. Unlike traditional inhibitors that merely block protein activity, degraders work by eliminating disease-causing proteins altogether through the ubiquitin–proteasome system. Behind this elegant mechanism lies a delicate balance between three essential components — linkers, ligands, and...
0 Reacties 0 aandelen 67 Views 0 voorbeeld
Sponsor
Sponsor
Sponsor
google-site-verification: google037b30823fc02426.html